RARE vs TMP
Ultragenyx (RARE) versus Tompkins Financial Corporation (TMP) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Tompkins Financial Corporation (TMP) is a banks - regional company listed on AMEX.
Latest reported RARE revenue for 2024-12-31 was $560.2M. Net income was -$569.2M. Revenue was up 29.0% from 2023-12-31 to 2024-12-31. RARE currently screens at market cap $2.79B.
Latest reported TMP revenue for 2024-12-31 was $79.3M. Net income was $71.0M. Revenue was up 5.7% from 2023-12-31 to 2024-12-31. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
RARE currently screens at market cap $2.79B. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
Not investment advice. Open the RARE and TMP stock pages for the full models.
Not investment advice.